UB-165
UB-165 is a drug that acts as a potent agonist for both the nicotinic acetylcholine receptors and the serotonin receptors. It is used in scientific research to understand the interaction between these two systems.
Pharmacology[edit | edit source]
UB-165 is a cholinergic drug, meaning it interacts with the cholinergic system in the brain. This system uses the neurotransmitter acetylcholine to send signals between nerve cells. UB-165 acts as an agonist for the nicotinic acetylcholine receptors, meaning it binds to these receptors and activates them.
In addition to its effects on the cholinergic system, UB-165 also interacts with the serotonergic system. This system uses the neurotransmitter serotonin to send signals. UB-165 acts as an agonist for the serotonin receptors, meaning it also binds to these receptors and activates them.
Uses in Research[edit | edit source]
UB-165 is used in scientific research to understand the interaction between the cholinergic and serotonergic systems. By activating both the nicotinic acetylcholine receptors and the serotonin receptors, researchers can study the effects of these two systems working together.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
